These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34562767)

  • 1. Optic neuritis in Asian type opticospinal multiple sclerosis (OSMS-ON) in a non-Asian population: A functional-structural paradox.
    Meneguette NS; Almeida KMFR; Figueiredo MTJO; de Araújo E Araújo ACR; Alvarenga MP; Vasconcelos CCF; Nascimento ACB; Colombini GNUI; Petzold A; Alvarenga RMP
    Mult Scler Relat Disord; 2021 Nov; 56():103260. PubMed ID: 34562767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
    Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of optical coherence tomography inter-eye percentage difference for optic neuritis in multiple sclerosis.
    Coric D; Balk LJ; Uitdehaag BMJ; Petzold A
    Eur J Neurol; 2017 Dec; 24(12):1479-1484. PubMed ID: 28887838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
    Chen JJ; Sotirchos ES; Henderson AD; Vasileiou ES; Flanagan EP; Bhatti MT; Jamali S; Eggenberger ER; Dinome M; Frohman LP; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Hellmann MA; Hodge D; Oertel FC; Paul F; Saidha S; Calabresi PA; Pittock SJ
    Mult Scler Relat Disord; 2022 Feb; 58():103525. PubMed ID: 35038647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
    Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU;
    J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thickness of macular inner retinal layers and peripapillary retinal nerve fibre layer in neuromyelitis optica spectrum optic neuritis and isolated optic neuritis with one episode.
    Peng C; Wang W; Xu Q; Yang M; Zhou H; Zhao S; Wei S
    Acta Ophthalmol; 2017 Sep; 95(6):583-590. PubMed ID: 27775238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers.
    Coric D; Balk LJ; Verrijp M; Eijlers A; Schoonheim MM; Killestein J; Uitdehaag BM; Petzold A
    Mult Scler; 2018 Feb; 24(2):158-166. PubMed ID: 28273785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of retinal atrophy in multiple sclerosis: A longitudinal study using spectral domain optical coherence tomography with segmentation analysis.
    Behbehani R; Adnan H; Al-Hassan AA; Al-Salahat A; Alroughani R
    Mult Scler Relat Disord; 2018 Apr; 21():56-62. PubMed ID: 29459346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
    Martinez-Lapiscina EH; Arnow S; Wilson JA; Saidha S; Preiningerova JL; Oberwahrenbrock T; Brandt AU; Pablo LE; Guerrieri S; Gonzalez I; Outteryck O; Mueller AK; Albrecht P; Chan W; Lukas S; Balk LJ; Fraser C; Frederiksen JL; Resto J; Frohman T; Cordano C; Zubizarreta I; Andorra M; Sanchez-Dalmau B; Saiz A; Bermel R; Klistorner A; Petzold A; Schippling S; Costello F; Aktas O; Vermersch P; Oreja-Guevara C; Comi G; Leocani L; Garcia-Martin E; Paul F; Havrdova E; Frohman E; Balcer LJ; Green AJ; Calabresi PA; Villoslada P;
    Lancet Neurol; 2016 May; 15(6):574-84. PubMed ID: 27011339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum Neurofilament Light Chain With Inner Retinal Layer Thinning in Multiple Sclerosis.
    Sotirchos ES; Vasileiou ES; Filippatou AG; Fitzgerald KC; Smith MD; Lord HN; Kalaitzidis G; Lambe J; Duval A; Prince JL; Mowry EM; Saidha S; Calabresi PA
    Neurology; 2022 Aug; 99(7):e688-e697. PubMed ID: 35618438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography.
    Peng CX; Li HY; Wang W; Wang JQ; Wang L; Xu QG; Cao SS; Zhou HF; Zhao S; Wei SH
    Br J Ophthalmol; 2017 Aug; 101(8):1032-1037. PubMed ID: 28057643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.
    Manogaran P; Vavasour IM; Lange AP; Zhao Y; McMullen K; Rauscher A; Carruthers R; Li DKB; Traboulsee AL; Kolind SH
    Neuroimage Clin; 2016; 11():743-750. PubMed ID: 27330974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-regression approach to improve optical coherence tomography diagnostic accuracy in multiple sclerosis patients without previous optic neuritis.
    Chua J; Bostan M; Li C; Sim YC; Bujor I; Wong D; Tan B; Yao X; Schwarzhans F; Garhöfer G; Fischer G; Vass C; Tiu C; Pirvulescu R; Popa-Cherecheanu A; Schmetterer L
    Neuroimage Clin; 2022; 34():103010. PubMed ID: 35447469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
    Pisa M; Ratti F; Vabanesi M; Radaelli M; Guerrieri S; Moiola L; Martinelli V; Comi G; Leocani L
    Mult Scler; 2020 Sep; 26(10):1197-1206. PubMed ID: 31392924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.
    Oertel FC; Outteryck O; Knier B; Zimmermann H; Borisow N; Bellmann-Strobl J; Blaschek A; Jarius S; Reindl M; Ruprecht K; Meinl E; Hohlfeld R; Paul F; Brandt AU; Kümpfel T; Havla J
    J Neuroinflammation; 2019 Jul; 16(1):154. PubMed ID: 31345223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
    Havla J; Pakeerathan T; Schwake C; Bennett JL; Kleiter I; Felipe-Rucián A; Joachim SC; Lotz-Havla AS; Kümpfel T; Krumbholz M; Wendel EM; Reindl M; Thiels C; Lücke T; Hellwig K; Gold R; Rostasy K; Ayzenberg I
    J Neuroinflammation; 2021 May; 18(1):121. PubMed ID: 34051804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis.
    Behbehani R; Ali A; Al-Omairah H; Rousseff RT
    Mult Scler Relat Disord; 2020 Jun; 41():101988. PubMed ID: 32092503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis.
    Petzold A; Balcer LJ; Calabresi PA; Costello F; Frohman TC; Frohman EM; Martinez-Lapiscina EH; Green AJ; Kardon R; Outteryck O; Paul F; Schippling S; Vermersch P; Villoslada P; Balk LJ;
    Lancet Neurol; 2017 Oct; 16(10):797-812. PubMed ID: 28920886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.
    Pakeerathan T; Havla J; Schwake C; Salmen A; Bigi S; Abegg M; Brügger D; Ferrazzini T; Runge AK; Breu M; Kornek B; Bsteh G; Felipe-Rucián A; Ringelstein M; Aktas O; Karenfort M; Wendel E; Kleiter I; Hellwig K; Kümpfel T; Thiels C; Lücke T; Gold R; Rostasy K; Ayzenberg I
    J Neurol; 2022 Dec; 269(12):6366-6376. PubMed ID: 35869995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
    Song HL; Wei SH
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.